Spots Global Cancer Trial Database for hpv infection
Every month we try and update this database with for hpv infection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women | NCT05829629 | HPV Infection HPV-Related Cer... | FluBHPVE6E7 Placebo | 18 Years - 49 Years | BlueSky Immunotherapies GmbH | |
Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV | NCT04210336 | HPV Infection Lesion Cervix | PAPILOCARE PLACEBO | 30 Years - 65 Years | Procare Health Iberia S.L. | |
Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women | NCT05570331 | HPV Infection Cervical Cancer | HPV integration... | 20 Years - 70 Years | Tongji Hospital | |
Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection | NCT05003505 | Intestinal Micr... Vaginal Microbi... HPV Infection | Follow up | 20 Years - 65 Years | Fujian Maternity and Child Health Hospital | |
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) | NCT01300689 | HPV Infection HIV Infection Syphilis | 18 Years - | ChineseAMS | ||
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents | NCT05435209 | HPV Infection HPV Vaccination | Quadrivalent Hu... | 16 Years - 25 Years | University of Washington | |
Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females | NCT04965350 | HPV Infection | Recombinant Hum... | 9 Years - 30 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
The Organ Transplant Recipient HPV and Skin Cancer Study | NCT05284877 | Solid Organ Tra... Skin Cancer Skin Dysplasia HPV Infection Cervical Intrae... Cervical Cancer HPV-Related Mal... | No intervention | 18 Years - | Bispebjerg Hospital | |
Clinical Correlation Between Self-collected and Physician-collected HPV Screening Kits | NCT05679141 | HPV Infection Cervical Cancer | 21 Years - | Switch Health Solutions Inc. | ||
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial | NCT04679675 | Uterine Cervica... Uterine Neoplas... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Neoplasms Uterine Cervica... Uterine Disease... Cervical Cancer Cervical Dyspla... Human Papilloma... HPV-Related Cer... HPV Infection HPV-Related Mal... | Usual Care Education Direct Mail Opt-in | 30 Years - 64 Years | Kaiser Permanente | |
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women | NCT05829629 | HPV Infection HPV-Related Cer... | FluBHPVE6E7 Placebo | 18 Years - 49 Years | BlueSky Immunotherapies GmbH | |
HPV Prevalence in 16-20 Year Old Males | NCT04297670 | HPV Infection | Measurement of ... | 16 Years - 20 Years | Laval University | |
DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections | NCT05509413 | Cervix Dysplasi... HPV Infection | DEFLAGYN vagina... | 18 Years - | Ruhr University of Bochum | |
HPV Prevalence in 16-20 Year Old Males | NCT04297670 | HPV Infection | Measurement of ... | 16 Years - 20 Years | Laval University | |
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV | NCT04255849 | HPV Positive Or... HIV-1-infection HPV Infection | 9 valent human ... Saline Placebo | 20 Years - 50 Years | Weill Medical College of Cornell University | |
HPV Vaccine in Postpartum Women | NCT04430907 | HPV Infection | HPV 9-valent Va... | 18 Years - 26 Years | Milton S. Hershey Medical Center | |
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital) | NCT01159834 | Human Papilloma... Infection | 10 Years - 16 Years | Barretos Cancer Hospital | ||
Prevalence of ENT Diseseas | NCT06105346 | Conscripts Military Induct... ENT Disease Rhinosinusitis ... Rhinosinusitis HPV Infection HPV Vaccine Long COVID ENT Surgery | 17 Years - 19 Years | Medical University of Graz | ||
Clinic or Self-Sampling for Cervical Cancer Screening | NCT06177236 | Cervical Cancer HPV Infection | cervical cancer... | 30 Years - 65 Years | Istanbul University - Cerrahpasa (IUC) | |
The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief | NCT05990270 | Cancer of Cervi... HPV Infection | education | - | Kahramanmaras Sutcu Imam University | |
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China | NCT01021904 | HPV Infections Precancerous Di... Cervical Cancer HPV Related Dis... | Gardasil (VLP, ... | 13 Years - 15 Years | ChineseAMS | |
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China | NCT01021904 | HPV Infections Precancerous Di... Cervical Cancer HPV Related Dis... | Gardasil (VLP, ... | 13 Years - 15 Years | ChineseAMS | |
PCOM2 - The Physician Communication Intervention, Version 2.0 | NCT05336240 | HPV Infection Preventive Heal... | Physician Commu... Physician Commu... | 9 Years - 17 Years | University of Colorado, Denver | |
Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS) | NCT05341284 | HPV Infection Cervical Diseas... | Questionnaire S... | 9 Years - 45 Years | Peking University | |
HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents | NCT04438291 | HPV Infection Health Behavior Health Attitude | MDL-SHPVP 30-minute educa... | 14 Years - 17 Years | Chinese University of Hong Kong | |
Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases | NCT06302725 | HPV Infection Systemic Diseas... | Vaginal self sa... | 30 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV | NCT04155294 | Cervical Cancer HPV Infection HIV Infections | 25 Years - 64 Years | University of Oxford | ||
Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania | NCT04953130 | HPV Infection Vaccine Prevent... | Gardasil® HPV v... | 14 Years - 18 Years | London School of Hygiene and Tropical Medicine | |
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China | NCT01021904 | HPV Infections Precancerous Di... Cervical Cancer HPV Related Dis... | Gardasil (VLP, ... | 13 Years - 15 Years | ChineseAMS | |
Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine | NCT05340322 | Cervical Cancer HPV Infection HIV Infections | Colposcopy usin... | 30 Years - 49 Years | Duke University | |
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe | NCT04092257 | HPV Infection Cervical Cancer HIV Infections | VIA and thermoc... | 25 Years - 50 Years | UNC Lineberger Comprehensive Cancer Center | |
Immunogenicity of Fractional Dose of the HPV Vaccines | NCT05291871 | HPV Infection HPV Vaccine | HPV vaccine | 27 Years - 45 Years | University of Washington | |
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus | NCT05918510 | Squamous Cell C... Carcinomas of U... High-risk Human... Liquid Biopsy Lymph Node Meta... Occult Tumor of... | Study of Viral ... | 18 Years - | Regina Elena Cancer Institute | |
Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females | NCT04965350 | HPV Infection | Recombinant Hum... | 9 Years - 30 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls | NCT01381575 | Infections, Pap... | GSK Biologicals... | 9 Years - 25 Years | GlaxoSmithKline | |
Molecular Biology of Anal Cancer in HIV-Positive Patients | NCT00952874 | Carcinoma HIV Infections | 20 Years - 80 Years | University Hospital, Geneva | ||
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe | NCT04092257 | HPV Infection Cervical Cancer HIV Infections | VIA and thermoc... | 25 Years - 50 Years | UNC Lineberger Comprehensive Cancer Center | |
Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine | NCT05340322 | Cervical Cancer HPV Infection HIV Infections | Colposcopy usin... | 30 Years - 49 Years | Duke University | |
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection | NCT05283239 | HPV Infection LSIL, Low-Grade... HSIL, High-Grad... Virus Integrati... | Follow up | - | Fujian Maternity and Child Health Hospital | |
Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections | NCT01824992 | HPV Infection | Yallaferon® | 30 Years - 65 Years | Lee's Pharmaceutical Limited | |
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen | NCT04206813 | HPV Infection | Gardasil 9 2 do... Gardasil 9 3 do... Gardasil 9 resc... | 16 Years - 45 Years | Boston Medical Center | |
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years | NCT06041061 | HPV InfectioN HPV-Related Car... | Recombinant 14-... placebo | 18 Years - 45 Years | Sinocelltech Ltd. | |
Assessing Jet Administration of pBI-11 for the Treatment of Patients With HPV16/18+ | NCT06210854 | HPV Infection | pBI-11 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls | NCT01381575 | Infections, Pap... | GSK Biologicals... | 9 Years - 25 Years | GlaxoSmithKline | |
Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer | NCT02809352 | HPV Infection | Human papilloma... | 31 Years - 65 Years | CHU de Reims | |
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen | NCT04206813 | HPV Infection | Gardasil 9 2 do... Gardasil 9 3 do... Gardasil 9 resc... | 16 Years - 45 Years | Boston Medical Center | |
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years | NCT05262010 | HPV InfectioN HPV-Related Car... | 11-valent recom... placebo | 18 Years - 45 Years | National Vaccine and Serum Institute, China | |
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
ELEVATE Acceptability Study | NCT06136702 | Cervical Cancer HPV Infection Acceptability o... | Educational ses... Self-sampling Follow-up asses... | 25 Years - 65 Years | University Ghent | |
HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix | NCT04333212 | Cervical Intrae... Human Papilloma... HPV Infection | DR. Chip HPV ge... | 21 Years - 65 Years | Chang Gung Memorial Hospital | |
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants | NCT06291311 | HPV Infection Cervical Cancer | Cold physical P... Control group | 18 Years - | University Hospital Tuebingen | |
Hospital-based Validation of the New ELEVATE Screening Tool in Belgium and Ecuador | NCT06304610 | Cervical Cancer HPV Infection | Questionnaire HPV self-sample Endocervical sa... | 30 Years - 65 Years | University Hospital, Ghent | |
Assessing Jet Administration of pBI-11 for the Treatment of Patients With HPV16/18+ | NCT06210854 | HPV Infection | pBI-11 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus | NCT05918510 | Squamous Cell C... Carcinomas of U... High-risk Human... Liquid Biopsy Lymph Node Meta... Occult Tumor of... | Study of Viral ... | 18 Years - | Regina Elena Cancer Institute | |
The SPOT-HPV Study | NCT05524025 | HPV Infection HPV Positive Or... | Salivary TTMV-H... Blood TTMV-HPV ... | 18 Years - | Dana-Farber Cancer Institute | |
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | NCT05672927 | Immunization HPV Infection Human Papilloma... | 9-valent HPV va... 9-valent HPV va... | 27 Years - 45 Years | The University of Texas Medical Branch, Galveston | |
Clinic or Self-Sampling for Cervical Cancer Screening | NCT06177236 | Cervical Cancer HPV Infection | cervical cancer... | 30 Years - 65 Years | Istanbul University - Cerrahpasa (IUC) | |
1:1 Comparison of the Pocket Colposcope in Kenya | NCT04998318 | Cervical Cancer HPV Infection HIV Infections | Pocket Colposco... Standard of Car... | 25 Years - 65 Years | Duke University | |
HPV DNA Self-sampling in a General Practitioner's Office. | NCT06253169 | Cervical Cancer HPV Infection Precancerous Le... | HPV DNA self-te... | 30 Years - | Patient Organization Veronica | |
Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV | NCT04210336 | HPV Infection Lesion Cervix | PAPILOCARE PLACEBO | 30 Years - 65 Years | Procare Health Iberia S.L. | |
Intradermal, Fractional Dose of HPV Vaccines: | NCT04235257 | HPV Infection HPV Vaccine | HPV vaccine | 27 Years - 45 Years | University of Washington | |
Human Papillomavirus in Young People Epidemiological Research 3 | NCT05587725 | Human Papilloma... HPV HPV Infection Anal Cancer Cancer Men HPV 16 Infectio... | 16 Years - 20 Years | Monash University | ||
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | NCT05672927 | Immunization HPV Infection Human Papilloma... | 9-valent HPV va... 9-valent HPV va... | 27 Years - 45 Years | The University of Texas Medical Branch, Galveston | |
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65 | NCT05414929 | HPV Infection Cervical Cancer... | HPV self-sampli... | 21 Years - 65 Years | Université de Sherbrooke | |
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV | NCT02403505 | HPV Infection | 9vHPV Vaccine p... | 24 Years - 64 Years | Medicine Invention Design, Inc | |
Prevention and Screening Towards Elimination of Cervical Cancer | NCT05234112 | HPV Infection Cervix Cancer Cervical Dyspla... | Community mobil... hrHPV self-test... Follow-up after... VIA Thermo-ablation... Pap smear cytol... | 30 Years - 60 Years | University Medical Center Groningen | |
Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys | NCT04711265 | HPV Vaccine HPV Infection HIV-1-infection | Quadrivalent HP... | 9 Years - 14 Years | Kenya Medical Research Institute | |
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants | NCT06291311 | HPV Infection Cervical Cancer | Cold physical P... Control group | 18 Years - | University Hospital Tuebingen | |
CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas | NCT02981862 | Cervical Cancer Vulvar Cancer Anal Cancer Oropharynx Canc... Oral Cavity Can... Penis Cancer | CaptHPV method | 18 Years - | Institut de Cancérologie de Lorraine | |
Prognostic Study of HPV Virus Integration in Women With HSIL | NCT05745597 | HPV Infection Virus Integrati... HSIL, High Grad... | Follow up | - | Fujian Maternity and Child Health Hospital | |
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65 | NCT05414929 | HPV Infection Cervical Cancer... | HPV self-sampli... | 21 Years - 65 Years | Université de Sherbrooke | |
Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections | NCT01824992 | HPV Infection | Yallaferon® | 30 Years - 65 Years | Lee's Pharmaceutical Limited | |
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) | NCT01300689 | HPV Infection HIV Infection Syphilis | 18 Years - | ChineseAMS | ||
The SPOT-HPV Study | NCT05524025 | HPV Infection HPV Positive Or... | Salivary TTMV-H... Blood TTMV-HPV ... | 18 Years - | Dana-Farber Cancer Institute | |
Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys | NCT04711265 | HPV Vaccine HPV Infection HIV-1-infection | Quadrivalent HP... | 9 Years - 14 Years | Kenya Medical Research Institute | |
Evaluation of the Prevalence of Oral HPV Infection in Patients Who Are Positive to the PAP-test | NCT05949398 | HPV Infection | 18 Years - 80 Years | University of Catania | ||
Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection | NCT05283239 | HPV Infection LSIL, Low-Grade... HSIL, High-Grad... Virus Integrati... | Follow up | - | Fujian Maternity and Child Health Hospital | |
Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions | NCT04607850 | HPV Infection CIN1 | ChAdOx1-HPV MVA-HPV Placebo | 25 Years - 55 Years | Barinthus Biotherapeutics | |
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries | NCT06002126 | Cervix Cancer HPV Infection Cervical High G... HIV Infections | Xpert HPV S5 DNA methylat... | 25 Years - 65 Years | Weill Medical College of Cornell University |